From massive genome-wide association studies to understand alcohol and substance abuse, down to the level of “epi-mutations” which can contribute to cancer formation, the Hackensack Meridian Center for Discovery and Innovation (CDI)’s first major gathering this year was a resounding success.
The inaugural “Genomic Medicine Symposium: From Bench to Bedside” featured eight noted experts during the all-day event on Feb. 19, was attended by about 100 people.
“The CDI continues to impress – not just with its groundbreaking discoveries, but also as an invaluable hub of science and learning,” said Robert C. Garrett, FACHE, chief executive officer of Hackensack Meridian Health.
“This was a terrific event,” said David Perlin, Ph.D., chief scientific officer and vice president of the CDI. “We heard about exciting future pathways in genomic science that will revolutionize medical science and precision medicine approaches in the years to come.”
“We are proud to have hosted this event and been a hub for this exceptional group of scientists at the top of this exploding field,” added Benjamin Tycko, M.D., Ph.D., a member of the CDI, and one of the organizers of the event.